Smart-Money SignalNeutral · 46/100— Insiders are net sellers over 90 days (-$1.1M, 8 sales vs 8 buys)
Revenue$44.7M
Net Income-$100.7M
EPS$-3.38
Market Cap$2.0B
Price Performance
Historical data including institutional events
Company Profile
B
Brian Goff
CEO & Executive Director
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
